NONEXOMICS
NonExomics integrates genomics, transcriptomic, and proteomics data by utilizing proprietary machine learning approaches to predict structures of nonexomic proteins and identifies disease-specific nonexomic targets, allowing clients to find cures for rare diseases.
NONEXOMICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Acton, Massachusetts, United States
Country:
United States
Website Url:
http://www.nonexomics.com
Total Employee:
1+
Status:
Active
Contact:
6178162721
Total Funding:
200 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Arvinas
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Current Employees Featured
Founder
Investors List
Illumina Accelerator
Illumina Accelerator investment in Non Equity Assistance - NonExomics
Official Site Inspections
http://www.nonexomics.com
- Host name: ec2-3-208-135-31.compute-1.amazonaws.com
- IP address: 3.208.135.31
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "NonExomics"
NonExomics - Redefining Medicinal Genomics
Our robust and rigorous machine learning based platform, developed over the last 8 years, has enabled us to query the entire human genome, transcriptome, and proteome and to discover …See details»
About Us - NonExomics
NonExomics’ science and platform, developed over 8 years of rigorous academic and industry research, mines novel disease-associated proteins from the entire human genome. NonExomics, LLC was founded in Boston, US, by scientists, …See details»
NonExomics - Crunchbase Company Profile & Funding
NonExomics integrates genomics, transcriptomic, and proteomics data by utilizing proprietary machine learning approaches to predict structures of nonexomic proteins and identifies disease-specific nonexomic targets, allowing clients to …See details»
NonExomics - LinkedIn
NonExomics, Inc is a scientists-led company that has pioneered the discovery process of the new wave of targets from the so-called Dark Genome.See details»
NonExomics Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for NonExomics. Use the PitchBook Platform to explore the full profile.See details»
NonExomics | LinkedIn
Redefining Medicinal Genomics | NonExomics, Inc is a scientists-led company that has pioneered the discovery process of the new wave of targets from the so-called Dark Genome. Over the …See details»
Our Genomics Services - NonExomics
Although we have our own inhouse prioritized targets spanning 1365 human diseases we are open to collaborate with biotech companies, pharmaceutical companies, academia, or any other interested entities to identify targets for …See details»
NonExomics - Contacts, Employees, Board Members, Advisors
NonExomics has 3 current employee profiles, including Co-Founder and CTO Sudhakaran Prabakaran. NonExomics develops therapeutics to diagnose and cure diseases emanating …See details»
TechBio innovator spotlight: NonExomics | BIA - bioindustry.org
NonExomics is headquartered in Boston, US since 2021 and has subsidiary branches in Cambridge, UK and Chennai, India. Interview with CEO, CTO, and Co-founder, Sudhakaran …See details»
NonExomics - Company info. interviews, news
Nov 14, 2022 · NonExomics apply machine learning technology to discover drugs for diseases arising specifically from non-exom issues. The company integrates all kinds of omics data – …See details»
NonExomics - VentureRadar
NonExomics has identified, using AI & Proteogenomics, hundreds of new disease-associated biomarkers spanning > 300 human diseases. NonExomics has shown that these disease …See details»
NonExomics - Products, Competitors, Financials, Employees, …
NonExomics is a company focused on medicinal genomics, specifically in the discovery and investigation of new proteins for disease treatment. Use the CB Insights Platform to explore …See details»
NonExomics Announces New Research That Can Aid in Obtaining …
Jun 21, 2022 · NonExomics has developed technology that leverages a combination of artificial intelligence, proteomics, transcriptomics, and genomics to scan carefully through the entire …See details»
Ruchi Chauhan, Ph.D. - NonExomics
She has 20 years of research experience working in proteogenomics, molecular target validation, drug discovery, cancer, and neurodegenerative disorders. She was the head of the Gene …See details»
NonExomics Unveils Technology to Decode Dark Genome for …
Jun 20, 2022 · NonExomics specializes in new technology that effectively leverages AI and proteogenomics (which studies how the DNA in a cell is linked to the proteins made by that …See details»
NonExomics Unveils Technology to Decode Dark Genome for
Jun 20, 2022 · NonExomics has announced the launch of new technology to explore the dark genome for rapid diagnosis and treatment of many common diseases like cancer, bipolar …See details»
NonExomics – Startups.Bio
Jan 5, 2022 · NonExomics is focused on the non-exome regions of the genome and has identified hundreds of potential new drug targets across rare diseases, neuropsychiatric disorders, and …See details»
NonExomics - LinkedIn
Redefining Medicinal Genomics | NonExomics, Inc is a scientists-led company that has pioneered the discovery process of the new wave of targets from the so-called Dark Genome. Over the …See details»
News - NonExomics
Nov 18, 2014 · NonExomics Unveils Technology to Decode Dark Genome for Diagnosis and Treatment of Diseases Like Cancer. Read MoreSee details»
Ordaōs/NonExomics deal shines light on novel mini-proteins
Sep 29, 2022 · NonExomics’ approach leverages artificial intelligence (AI) and proteogenomics – how DNA is linked to the proteins it codes for – to identify hundreds of new disease-associated …See details»